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Objective: Ultrasound (US) and magnetic resonance imaging (MRI) are recommended in the diagnostic process
of rheumatoid arthritis. Research on its comparability in early disease phases is scarce. Therefore, we compared
synovitis and tenosynovitis detected by US and MRI on joint/tendon level.
Methods: Eight hundred forty joints and 700 tendons of 70 consecutive patients, presenting with inflammatory
arthritis or clinically suspect arthralgia, underwent US and MRI of MCP (2–5), wrist and MTP (1–5) joints at the
same day. Greyscale (GS) and power Doppler (PD) synovitis were scored according to the modified Szkudlarek
method (combining synovial effusion and hypertrophy) and the recently published EULAR-OMERACT method
(synovial hypertrophy regardless of the presence of effusion) on static images. US-detected tenosynovitis was
scored according to the OMERACT. MRI scans were scored according to the RAMRIS. Test characteristics were
calculated on joint/tendon level with MRI as reference. Cut-off for US scores were ≥ 1 and ≥ 2 and for MRI ≥ 1.
Results: Compared to MRI, GS synovitis according to EULAR-OMERACT (cut-off ≥ 1) had a sensitivity ranging from
29 to 75% for the different joint locations; specificity ranged from 80 to 98%. For the modified Szkudlarek method,
the sensitivity was 68–91% and specificity 52–71%. PD synovitis had a sensitivity of 30–54% and specificity 97–99%
compared to MRI. The sensitivity to detect GS tenosynovitis was 50–78% and the specificity 80–94%. For PD
tenosynovitis, the sensitivity was 19–58% and specificity 98–100%.
Conclusion: Current data showed that US is less sensitive than MRI in the early detection of synovitis and
tenosynovitis, but resulted in only few non-specific findings. The higher sensitivity of MRI is at the expense of less
accessibility and higher costs.
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The value of sensitive imaging methods such as muscu-
loskeletal ultrasound (US) and magnetic resonance im-
aging (MRI) for disease monitoring in rheumatoid arthritis
(RA) is currently being discussed [1]. The diagnostic value
of US and MRI in very early disease phases of RA is also
being investigated, and there appears to be an agreement
on the notion that these modalities have an added value in
the diagnostic process [1]. The EULAR imaging taskforce
also recommended the use of US and MRI for this purpose
without distinguishing between both modalities [2]. These
modalities have advantages and disadvantages. MRI is gen-
erally considered as the most valid method, yielding repro-
ducible results in a three-dimensional view, and it has the
advantage that it depicts bone marrow oedema. Its use is
limited by insufficient availability in several centres and
higher costs. A disadvantage of US is the machine and op-
erator dependency. Currently available data obtained in pa-
tients at risk for RA revealed that US-detected synovitis or
tenosynovitis scores (greyscale (GS) or power Doppler
(PD)) and MRI-detected synovitis or tenosynovitis scores
were predictive for RA development [3–10]. These studies
generally used only one modality and did not directly com-
pare findings of both modalities.
Presently, there is limited knowledge whether US and
MRI identify the same lesions in the earliest phase of
RA. One study compared MRI and US on joint/tendon
level in patients with early classified RA; data suggested
that MRI is more sensitive than US [11]. The existing
studies in early arthritis or arthralgia that performed
both MRI and US did not make comparisons on joint
or tendon level, did not include the feet, or used
low-field MRI [12–15]. In addition, only few studies in-
cluded tenosynovitis [11–13], and none of them used
standardised scoring methods such as the recently pub-
lished EULAR-OMERACT method for US scoring [16].
Therefore, we aimed to evaluate to what extent both
modalities can be used interchangeably in patients at
risk for RA. We conducted a cross-sectional study in
patients presenting with early inflammatory arthritis
(IA) or clinically suspect arthralgia (CSA) and investi-
gated on joint and tendon levels whether US and MRI
detected the same inflammatory lesions (synovitis and
tenosynovitis).Methods
Patients
Patients that newly presented with early IA or CSA be-
tween May and October 2017 at the Leiden rheumatology
outpatient clinic were studied. They were consecutively in-
cluded in either the Early Arthritis Clinic (EAC) cohort or
the CSA cohort. Requirements for inclusion in both co-
horts are described in reference and supplementary [8, 17].Both cohort studies were approved by the local Med-
ical Ethical Committee. All patients provided informed
consent.
Study protocol
All patients underwent unilateral contrast-enhanced MRI
of metacarpophalangeal (MCP), wrist, and metatarsopha-
langeal (MTP) joints and musculoskeletal US at the same
day < 2 weeks after first presentation. According to the
protocol, imaging was done before disease-modifying anti-
rheumatic drug (DMARD) initiation (including gluco-
corticoids) in patients with IA. DMARDs were not pre-
scribed to patients with CSA. All patients were asked to
stop NSAIDs 24 h before imaging. More details are pro-
vided supplementary.
MR imaging and scoring
All patients were scanned on the same scanner (an
MSK Extreme 1.5 T extremity MR system (GE Health-
care, Wisconsin, USA)). Unilateral MRI scans of wrist,
MCP (2–5) and MTP (1–5) joints were made of the
most affected side, or the dominant side in case of
equally severe symptoms. Sequences acquired were cor-
onal pre-contrast T1-weighted fast spin-echo (FSE) and
coronal and axial post-contrast T1-weighted FSE with
frequency-selective fat suppression of MCP and wrist,
and post-contrast coronal and axial sequences of the
MTP joints. More details are provided in reference and
supplementary [17].
Each MRI-scan was scored according to RA MRI
scoring (RAMRIS) method by two experienced readers
(inter-reader intraclass correlation coefficients (ICC) >
0.94) [18, 19]. MRI scores for joints (synovitis) and ten-
dons (tenosynovitis) ranged from 0 to 3. Mean scores
of two readers were calculated and lesions were consid-
ered absent in case it was scored by only one reader.
Musculoskeletal ultrasound scanning and scoring
A high-end US machine was used (GE Logiq E9, Ge-
nova, Italy) with a linear array transducer of 6–15MHz.
US examinations were performed bilaterally in GS and
PD mode according to a standardised protocol. The
same locations that were scanned by MRI were studied
here. PD was assessed with a pulse repetition frequency
of 0.8 kHz, and gain was set to a level until background
signal was removed.
The presence of synovitis was assessed on a semi-
quantitative scale (0–3) for GS/PD according to Szku-
dlarek et al. [20], and synovial effusion and hypertrophy
were combined (called ‘modified Szkudlarek method’) [21].
Tenosynovitis was examined on a semi-quantitative scale
(0–3) for GS/PD according to OMERACT [22]. A detailed
US-scoring protocol is provided supplementary. All US
scores per joint/tendon ranged from 0 to 3.
Table 1 Baseline characteristics of 70 patients studied
All patients
(n = 70)
Age, mean (SD) 50 (15)
Female, n (%) 43 (61)
68-Tender joint count, median (IQR) 5 (2–8)
66-Swollen joint count, median (IQR)* 2 (1–6)
CRP (mg/L), median (IQR) 3 (3–11)
RF positive (≥ 3.5 IU/mL), n (%) 20 (29)
ACPA positive (≥ 7 U/mL), n (%) 16 (23)
Either RF or ACPA positive, n (%) 22 (31)
*Swollen joint count based on inflammatory arthritis (IA) patients, as all
clinically suspect arthralgia (CSA) patients per definition do not have
swollen joints
ACPA anti-citrullinated peptide antibody (anti-CCP2, EliA CCP, Phadia, the
Netherlands, positive if ≥ 7 U/mL), RF immunoglobulin M-rheumatoid factor
(positive if ≥ 3.5 IU/mL), CRP c-reactive protein (positive if ≥ 5mg/L), SD
standard deviation, IQR inter quartile range
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OMERACT-scoring method for synovitis was published
[16]. To explore if the results changed when this defin-
ition was used, the static images of US were re-scored
for GS synovitis by two examiners (ICC 0.92) and mean
scores were calculated. The different scoring methods
are described in Additional file 1: Table S1 and in the
supplementary methods.
Imaging results were not communicated to clinicians
at any time point.
Statistical analyses
We compared semi-quantitative scores of US-detected
synovitis and tenosynovitis to MRI-detected synovitis
and tenosynovitis scores (each on a scale from 0 to 3),
respectively, for each location using spearman’s correl-
ation coefficients. For the primary analyses, we used the
method according to the EULAR-OMERACT for GS
synovitis. After analysing (semi-)quantitative data, US
and MRI scores were dichotomized. For US, different
cut-offs were studied: ≥ 1 and ≥ 2 for GS synovitis, ≥ 1
for PD synovitis and ≥ 1 for GS/PD tenosynovitis. Add-
itionally, GS synovitis and tenosynovitis scores ≥ 2 or PD
≥ 1 were combined. MRI scores were dichotomized with
≥ 1 as cut-off and also on a cut-off based on findings
from symptom-free volunteers, which has been pub-
lished previously [23]. Then, an MRI was considered
positive if synovitis or tenosynovitis was seen in < 5% of
age-matched healthy controls. We calculated test char-
acteristics for US with MRI as reference. Analyses were
done on individual joint/tendon level and firstly pre-
sented on joint-group level (wrist, MCP, MTP joints) for
reasons of clarity. Sub-analyses included stratification for
patients presenting with IA and CSA and presentation
of data at individual joint/tendon level. Finally, for GS
synovitis, the ‘modified Szkudlarek method’ was com-
pared to the EULAR-OMERACT method and also com-
pared to MRI [16, 18, 21]. IBM SPSS (New York, USA)
v23 was used.
Results
Study population
Seventy patients newly presenting to the rheumatology
outpatient clinic (40 with recent-onset CSA, 30 with
early IA) were included. Table 1 presents their baseline
characteristics. The majority was female; mean age was
45 for patients with CSA and 57 for patients with IA
(Additional file 1: Table S2). In total, 840 joints and
700 tendons were examined.
Synovitis detected by US versus MRI
Figure 1(a–c) presents the scores for GS-detected syno-
vitis (EULAR-OMERACT method) versus MRI-detected
synovitis (OMERACT-RAMRIS method). Analyses wereperformed on individual joints and tendons (i.e. MCP-2
of US versus MRI) and presented per joint group (MCPs,
wrist, MTPs). All scores within joint groups were signifi-
cantly correlated (Additional file 1: Table S3). In MTP
joints, MRI scores of 0 infrequently coincided with scores
of 1 for US (Fig. 1c); this is in contrast to findings on
MCP and wrist level (Fig. 1a, b). In line with this observa-
tion, the corresponding test characteristics showed a high
specificity (> 90%) for GS synovitis of wrist and MCP
joints and a somewhat lower specificity of 80% for MTP
joints. The sensitivity was poor for MCP and wrist (29–
39%) and higher (75%) for MTP joints with MRI as refer-
ence (Table 2)
Subsequently, PD synovitis scores were compared to
MRI. Also here, increased US scores were accompanied
by increased MRI scores, and correlations were statisti-
cally significant (Additional file 1: Table S3). As pre-
sented (Fig. 1d–f ), PD scores were only rarely ≥ 1 when
MRI-detected synovitis scores were 0. Furthermore, we
observed regularly that PD scores were 0 for joints that
were scored ≥ 1 by MRI. These observations were reflected
by the test characteristics, which showed a high specificity
for PD (97–99%) for all locations (MTP, MCP, wrist) with
only a low to moderate sensitivity (30–54%, Table 2).
Test characteristics when US positivity was defined by
a combination of GS scores ≥ 2 or PD ≥ 1 are provided
in Table 2. The combined scores showed a high specifi-
city (> 92%) accompanied by an increased sensitivity for
the MCP and wrist joints (30–54%) but not for the MTP
joints (68%) in comparison to GS/PD alone.
Tenosynovitis detected by US versus MRI
Figure 2(a–c) presents the data of GS-detected tenosyno-
vitis versus MRI-detected tenosynovitis scores. MRI scores
were significantly correlated to GS scores (Additional file 1:
Table S3). However, scores ≥ 1 for MRI were also often
Fig. 1 Greyscale ultrasound (according to EULAR-OMERACT definition, a–c) and power Doppler ultrasound-detected synovitis (d–f) versus MRI-
detected synovitis on MCP, wrist and MTP joint level. Number of corresponding joints per MRI score was for a 0 = 222, 1 = 42, 2 = 7, 3 = 0; b 0 = 136,
1 = 55, 2 = 10, 3 = 1; c 0 = 285, 1 = 39, 2 = 5, 3 = 0; d 0 = 224, 1 = 48, 2 = 8, 3 = 0; e 0 = 137, 1 = 58, 2 = 14, 3 = 1; f 0 = 296, 1 = 39, 2 = 5, 3 = 0. Bars
indicate the mean
Table 2 Test characteristics for ultrasound-detected synovitis and tenosynovitis with MRI as reference
Sensitivity Specificity AUC Sensitivity Specificity AUC Sensitivity Specificity AUC
Synovitis GS ≥ 1 (EULAR-OMERACT) PD ≥ 1 GS ≥ 2 (EULAR-OMERACT) or PD ≥ 1
MCP joints 39 (27; 53) 98 (95; 99) 0.69 54 (41; 66) 97 (94; 99) 0.75 54 (41; 66) 97 (94; 99) 0.75
Wrist joints 29 (19; 40) 94 (89; 97) 0.61 30 (21; 41) 99 (95; 100) 0.64 30 (21; 41) 99 (95; 100) 0.64
MTP joints 75 (61; 85) 80 (75; 85) 0.78 41 (28; 56) 99 (97; 99) 0.70 68 (53; 80) 86 (81; 89) 0.77
Tenosynovitis GS ≥ 1 PD ≥ 1 GS ≥ 2 or PD ≥ 1
Extensor wrist tendons 78 (59; 86) 80 (74; 86) 0.78 58 (42; 73) 98 (95; 99) 0.78 67 (50; 80) 97 (93; 98) 0.82
Flexor wrist tendons 50 (31; 69) 94 (90; 97) 0.72 42 (24; 61) 99 (97; 100) 0.71 50 (31; 69) 99 (96; 100) 0.75
Flexor MCP tendons 74 (60; 84) 89 (84; 92) 0.81 19 (11; 31) 100 (98; 100) 0.59 36 (24; 49) 100 (98; 100) 0.68
Test characteristics are shown in percentages with a 95% CI except for the AUC, area under the receiver operating characteristic curve. GS greyscale, PD
power Doppler
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Fig. 2 Greyscale (a–c) and power Doppler ultrasound-detected tenosynovitis (d–f) versus MRI-detected tenosynovitis of MCP flexor 2–5, wrist
flexor and extensor tendons. Number of corresponding tendons per MRI score was for a 0 = 226, 1 = 52, 2 = 1, 3 = 0; b 0 = 186, 1 = 23, 2 = 1, 3 = 0;
c 0 = 173, 1 = 32, 2 = 5, 3 = 0; d 0 = 226, 1 = 52, 2 = 1, 3 = 0; e 0 = 185, 1 = 23, 2 = 1, 3 = 0; f 0 = 171, 1 = 32, 2 = 5, 3 = 0. Bars indicate the mean
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were in line with these observations, with a specificity
of 80% for the extensor wrist tendons and > 89% for the
other tendons (flexor wrist, flexor MCPs), and a moder-
ate sensitivity (50–78%, Table 2)
Figure 2(d–f ) shows the data of PD tenosynovitis
versus MRI. PD signals were infrequently increased.
MRI detected 113 tendons with tenosynovitis (out of
700), while for PD this was only 45. The correspond-
ing test characteristics in Table 2 showed a high speci-
ficity (98–100%) with a low to moderate sensitivity
(19–58%)
Defining tenosynovitis as a combination of GS ≥ 2 or
PD ≥ 1 slightly improved the test characteristics for the
extensor and flexor tendons of the wrist, but not for
the flexor tendons of the MCPs, compared to the separ-
ate ultrasound features (GS/PD) (Table 2).Cut-off for synovitis and tenosynovitis based on healthy
volunteers
To investigate whether the excess of increased MRI-
detected scores compared to US scores could be ex-
plained by the definition of positivity for MRI, we also
applied a cut-off based on findings from symptom-free
volunteers [23]. This resulted in a slightly increased
sensitivity and AUC for GS-detected (teno)synovitis,
while the specificity remained high compared to the
main analyses. For PD, it only caused small differences
(Additional file 1: Table S4).
Sub-analyses stratified for IA and CSA
In Additional file 1: Figures S1–S4, we provided the data
of the US synovitis and tenosynovitis scores (GS and
PD) versus MRI for patients with CSA and IA separately.
As expected, synovitis and tenosynovitis were less
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than IA. However, the pattern of concordance between
MRI and US was similar. We also calculated test charac-
teristics for patients with CSA and IA separately (Add-
itional file 1: Table S5). The sensitivity for US with MRI as
reference was lower in CSA than in patients with IA. The
specificity was similar in both populations.
Data presented on individual joint/tendon level
For clarity, the main results were presented on joint-
group level, although analyses were performed on
joint/tendon level. However, as findings on different
joints/tendons might be different and these differences
cannot be seen by presentation the joint-group level,
we also provided test characteristics for each joint/tendon
separately (Additional file 1: Tables S6, S7). In general, re-
sults were similar with a low to moderate sensitivity and
high specificity. Remarkably, for the flexor tendons of
the wrist (GS), all flexors had high specificity (88–
100%). However, the sensitivity varied broadly: 71% for
the FPL, 55% for the FCR and only 17% for the FDS/
FDP. Also for PD, the sensitivity for tenosynovitis was
generally low (17–64%).
Examples of MRI-detected (teno)synovitis versus GS/
PD are illustrated by Fig. 3.
Evaluation of two scoring methods for GS-detected
synovitis
Due to recent advances in scoring methods for GS, two
methods were applied and test characteristics were also
determined for GS by the modified Szkudlarek methodFig. 3 Examples of MRI-detected synovitis and tenosynovitis with correspo
inflammation identified by MRI that were verified through ultrasound (US).
scan, we choose to show the corresponding US images of only one joint o
MCP-3 by MRI, which was confirmed by greyscale (GS) and power Doppler
MCP-4 which was confirmed by GS but not by PD on US. c Inflammation
confirmed by both GS and PD on US[21] with MRI as reference (Table 3). The modified
Szkudlarek method had a higher sensitivity of 68–91%
and lower specificity of 52–71% than the EULAR-
OMERACT method (sensitivity 29–75%, specificity
80–98%) compared to MRI. Thereafter, we compared
the scores of the two scoring methods for GS for each
joint. The modified Szkudlarek method generally had
higher scores than the EULAR-OMERACT method
(see Additional file 1: Table S8–S10).
Discussion
This large cross-sectional study compared US and MRI
findings of synovitis and tenosynovitis on the joint and
tendon levels, respectively, in patients newly presenting
with early IA and CSA. These are the populations where
imaging modalities can have a specific role in the diagnos-
tic process. The newly developed EULAR-OMERACT-
scoring method for GS-detected synovitis for US was used.
Our data showed that US findings were highly specific and
rarely ‘false-positive’, but also less sensitive compared to
MRI, resulting in ‘false-negative results’. This suggests that
MRI cannot be replaced by US while maintaining its sensi-
tivity on the level of joints and tendons. How this affects
the predictive accuracy needs to be investigated further in
longitudinal studies.
Two different scoring methods for GS-detected syno-
vitis were applied: the EULAR-OMERACT method and
the modified Szkudlarek method, which combines syn-
ovial effusion and hypertrophy [16, 21]. Direct compari-
son of both scoring methods for GS synovitis showed that
higher scores were obtained by the modified Szkudlareknding greyscale and power Doppler ultrasound images. Examples of
Even though sometimes more inflammation was present on the MRI
r tendon that was present on the image. a An example of synovitis
(PD) US images of the same joint. b Tenosynovitis of the flexor of
of the extensor carpi ulnaris tendon at the wrist level which was
Table 3 Test characteristics for greyscale ultrasound-detected synovitis with MRI as a reference for the ‘old’ synovitis definition according
to the modified Szkudlarek method and for the ‘new’ EULAR-OMERACT synovitis definition
Sensitivity Specificity AUC Sensitivity Specificity AUC
Synovitis GS ≥ 1 (modified Szkudlarek) GS ≥ 2 (modified Szkudlarek)
MCP joints 73 (60; 83) 70 (64; 76) 0.72 39 (28; 52) 96 (93; 98) 0.68
Wrist joints 68 (57; 78) 71 (63; 78) 0.70 34 (24; 46) 97 (93; 99) 0.66
MTP joints 91 (79; 96) 52 (47; 58) 0.72 64 (49; 76) 92 (88; 94) 0.78
Synovitis GS ≥ 1 (EULAR-OMERACT) GS ≥ 2 (EULAR-OMERACT)
MCP joints 39 (27; 53) 98 (95; 99) 0.69 17 (9; 30) 100 (98; 100) 0.58
Wrist joints 29 (19; 40) 94 (89; 97) 0.61 9 (4; 17) 100 (97; 100) 0.54
MTP joints 75 (61; 85) 80 (75; 85) 0.78 23 (13; 37) 99 (97; 100) 0.61
Test characteristics are shown in percentages with a 95% CI except for the AUC, area under the receiver operating characteristic curve. GS greyscale
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fied Szkudlarek method had more false positives which re-
sulted in a higher sensitivity but lower specificity than the
EULAR-OMERACT method. The false-positive results
(MRI scores 0, GSUS > 0) obtained by the modified Szku-
dlarek method might be explained by the fact that it evalu-
ates a combination of synovial effusion and hypertrophy,
while in the recent EULAR-OMERACT definition hyper-
trophy regardless of the presence of synovial effusion was
evaluated [16], and the fact that contrast-enhanced MRI
also does not visualise joint effusion. Thus, although this
study did not primarily aim to compare the ‘old’ and ‘new’
GS synovitis scores, present data also showed the relation-
ship between both GS scoring methods and revealed that
the EULAR-OMERACT synovitis score for US was more
concordant to the OMERACT-RAMRIS method for MRI.
Unfortunately, the definition of the EULAR-OMERACT
for GS synovitis was published when this study had
already started [16]. Consequently, synovitis had already
been scored according to the modified Szkudlarek method.
Therefore, static US images were rescored according to
the EULAR-OMERACT method, which might be a poten-
tial limitation, as scoring of static images can be challen-
ging. We used two independent readers to assess the static
images; both readers showed excellent agreement between
the reading results, which supports the reliability of these
data.
Since the role of synovial effusion in the pathologic
process of RA and other types of IA is not yet fully under-
stood, synovial effusion was not explicitly taken into ac-
count, except within the modified Szkudlarek method [21].
Synovial effusion often has been detected in healthy per-
sons by US, especially in the feet [24]. Unfortunately, up to
now, age-related normal values for US-detected patholo-
gies such as synovial effusion, synovial hypertrophy, teno-
synovitis and erosions are still unknown and should be
subject for future studies. Furthermore, it would be inter-
esting to see the effect of findings in healthy symptom-free
individuals for the definition of positivity for US. This is
also subject for future research.Importantly, there were differences between the scor-
ing methods for US and MRI. All scoring methods con-
sisted of semi-quantitative scales ranging from 0 to 3.
However, the requirements for each grade were different
for US and MRI (Additional file 1: Table S1). Thus, dif-
ferent definitions for the different scoring methods ham-
per direct comparison of the different grades, though as
presented by Figs. 1 and 2, increased US scores generally
coincided with increased MRI scores. To assess whether
this was similar in patients with CSA and IA, we also re-
peated the analyses for both populations separately. In
both populations, higher US scores were present in pa-
tients with higher MRI scores (Additional file 1: Figures
S1–S4). However, the test characteristics were not com-
pletely similar. Although the specificity for US was similar
in both populations, the sensitivity was lower in patients
with CSA compared to IA. CSA patients have less severe
inflammation than patients with IA and current data im-
plied that in this setting of subclinical inflammation, US is
less sensitive than MRI.
Another issue is the cut-off used for dichotomization.
Our US cut-offs are frequently used in the literature. For
GS, we observed that increasing the cut-off from ≥ 1 to
≥ 2 resulted in an increased specificity and a notably de-
creased sensitivity. This phenomenon is often observed
when changing cut-offs. Based on AUCs, a cut-off ≥ 1
could be considered more favourably than ≥ 2. Also, the
cut-off for MRI positivity was explored. In addition to
using a cut-off of mean ≥ 1, we applied a cut-off based
on healthy volunteers [23]. This caused only minor im-
provements in the test characteristics for US compared
to MRI.
A strength of this study was that besides synovitis, also
tenosynovitis was evaluated; this imaging feature is less
often studied than synovitis while it is important, as
tenosynovitis in IA and CSA has been shown predictive
of RA development, both in studies that used MRI [9,
25] and US [7]. Furthermore, this study examined pa-
tients at risk for RA and applied the new EULAR-
OMERACT score for GS-detected synovitis. We also
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MTP joints. In contrast, a recent meta-analysis com-
pared the accuracy of US-detected synovitis versus MRI
in wrist, MCP, PIP, and knee joints, but not MTP joints
in patients with classified RA [26]. The included studies
were also not scored according to the EULAR-OMERACT
method. Despite these differences, the sensitivity and spe-
cificity for GS/PD-detected synovitis observed in this study
compared to our data are roughly similar. Also GS teno-
synovitis was previously studied by Wakefield et al. in
MCP joints of classified RA-patients and were comparable
to our results from patients in earlier disease phases,
showing a high specificity and moderate sensitivity [11].
In our data on tenosynovitis, the sensitivity was par-
ticularly low for the FDS/FDP tendon. A possible ex-
planation could be that this tendon is located below the
retinaculum flexorum, deeper in the wrist tissue than
other tendons. Also, PDUS tenosynovitis had only a low
to moderate sensitivity, despite the use of high-end US
machine with a sensitive power Doppler. PD-detected
tenosynovitis had only a small or no additive value to
GS tenosynovitis, particularly for the MCP-flexor ten-
dons. A reason for this could be that PD performs better
from the dorsal side of the joint than from the palmar
side, which may have contributed to this finding [16,
27]. Although replication in other studies is needed, the
current data with MR as reference suggests that PDUS-
detected tenosynovitis had no clear additive value to GSUS,
which is in contrast to findings for synovitis.
This cross-sectional study is the first that examined
the concordance between synovitis detected by US and
MRI in the feet of patients with (suspicion on imminent)
early RA. Interestingly, GS synovitis had a higher sensi-
tivity in the feet than in the hand joints, which was at the
cost of a lower specificity (implying a higher frequency of
false-positive signals in MTP joints).
MRI was the reference in this cross-sectional study on
the joint/tendon level, showing false-negative findings for
synovitis and tenosynovitis. For clinical purposes, analyses
on patient level are also relevant, as patients often have
> 1 joint affected and at least 1 joint with subclinical in-
flammation might be considered sufficient to indicate dis-
ease. Analyses on the patient level showed that US missed
only 1/44 patients (GS) and 14/44 (PD) compared to MRI
(cut-offs ≥ 1, data not shown). Hence, there is less discord-
ance on the patient level than on the joint/tendon level.
The comparability of US and MRI to accurately predict
RA development remains an outstanding question, for
which longitudinal studies with RA development as out-
come are needed.
In conclusion, this is the first study that used the re-
cently developed EULAR-OMERACT method for US in
comparison to MRI, in patients consecutively presenting
with early IA and CSA. These are the populations inwhich these imaging modalities can be used to detect
(imminent) RA. US had a good specificity, but was less
sensitive compared to MRI on the local tendon and joint
level. However, US is more easily available, less time-
consuming and has lower costs than MRI. Longitudinal
studies in ‘at-risk’ populations are needed to directly
compare the predictive accuracy of MRI and US while
using up-to-date scoring methods.
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